
The Overview: March 2022
There are so many ways to spring into action and knowledge around our shared mission. Read on to learn about promising research findings, how to make your voice heard, ways … Continued
There are so many ways to spring into action and knowledge around our shared mission. Read on to learn about promising research findings, how to make your voice heard, ways … Continued
Though palliative care and hospice care are both used to improve a patient’s quality of life, there are key distinctions between the two — as well as many commonly held … Continued
With tax season upon us, financial planning is on many people’s minds. While all gifts made by check or credit card are tax-deductible, there are other ways to fund cutting-edge … Continued
Update: On 3/11/22, President Biden SIGNED the FY2022 spending bill into law, implementing key ovarian cancer program increases. This represents a major win for the ovarian cancer community, and we … Continued
Dr. Melanie Weigert, of University of Chicago, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With her project, “Genome-Wide Profiling of 5-hydroxymethylcytosine on Cell-Free DNA,” Dr. Weigert aims to … Continued
Key recommendations for improving care of ovarian cancer patients in the United States have been published as part of a collaborative, in-depth initiative spearheaded by the Association of Community Cancer Centers … Continued
In promising news on the prevention front, one surgical procedure that leaves the ovaries intact may greatly reduce the risk of ovarian cancer. Recent research findings show that the surgical … Continued
This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all … Continued
Cervical cell samples that are routinely collected as part of Pap smears may hold promise for predicting the risk of ovarian and other cancers, according to recent findings published as … Continued
The ovarian cancer community is counting on a hero… and that OCRA Hero could be you! If you’re looking to do good in 2022, it can be as simple (and … Continued
A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing chemotherapy treatment around the … Continued
Over the past decade, a new class of drugs called PARP inhibitors have been approved by the Food and Drug Administration (FDA) for use in ovarian cancer. Three FDA-approved PARP … Continued
Get email updates about research news, action alerts, and ways to join the fight.